Fortrea Holdings (FTRE) Interest Coverage Ratio (2022 - 2026)
Fortrea Holdings (FTRE) posted Interest Coverage Ratio of 0.15 for Q1 2026, up 50.0% on a QoQ basis from 0.29 in Q4 2025, and up 99.04% year-over-year from 0.07 in Q1 2025.
Fortrea Holdings (FTRE) Interest Coverage Ratio (2022 - 2026) Analysis & Trends
Fortrea Holdings' Interest Coverage Ratio history runs 5 years deep, the most recent figure standing at 0.15 for Q1 2026.
- Quarterly Interest Coverage Ratio rose 99.04% year-over-year to 0.15 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 3.65 (up 39.35% YoY) and the FY2025 annual result came in at 18.18, down 1130.66% from the prior year.
- Interest Coverage Ratio was 0.15 for Q1 2026 at Fortrea Holdings, up from 0.29 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 141.0 in Q1 2023 and bottomed at 27.52 in Q2 2025.
- A 5-year average of 6.46 and a median of 0.44 in 2024 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2025 — Interest Coverage Ratio tumbled 2582.2% — and 2026, when it jumped 99.04%.
- Fortrea Holdings' Interest Coverage Ratio stood at 0.28 in 2022, then slumped by 380.46% to 0.8 in 2023, then slumped by 517.09% to 4.92 in 2024, then surged by 94.09% to 0.29 in 2025, then soared by 50.0% to 0.15 in 2026.
- Business Quant data shows FTRE's Interest Coverage Ratio at 0.15 in Q1 2026, 0.29 in Q4 2025, and 0.31 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Fortrea Holdings | 1.83 Bn | 1.68 Bn | 123.60 Mn | -0.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.15 |
| Dec 31, 2025 | -0.29 |
| Sep 30, 2025 | -0.31 |
| Jun 30, 2025 | -27.53 |
| Mar 31, 2025 | -15.21 |
| Dec 31, 2024 | -4.92 |
| Sep 30, 2024 | -0.57 |
| Jun 30, 2024 | -1.03 |
| Mar 31, 2024 | -0.75 |
| Dec 31, 2023 | -0.80 |
| Sep 30, 2023 | 0.17 |
| Jun 30, 2023 | 0.53 |
| Mar 31, 2023 | 141.00 |
| Dec 31, 2022 | 0.28 |